SOX9 Protein Induces a Chondrogenic Phenotype of Mesangial Cells and Contributes to Advanced Diabetic Nephropathy-Reference-Cited by-同舟云学术

SOX9 Protein Induces a Chondrogenic Phenotype of Mesangial Cells and Contributes to Advanced Diabetic Nephropathy

Published:2011-09 Issue:37 Volume:286 Page:32162-32169
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kishi Seiji,Abe Hideharu,Akiyama Haruhiko,Tominaga Tatsuya,Murakami Taichi,Mima Akira,Nagai Kojiro,Kishi Fumi,Matsuura Motokazu,Matsubara Takeshi,Iehara Noriyuki,Ueda Otoya,Fukushima Naoshi,Jishage Kou-ichi,Doi Toshio

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference56 articles.

1. Glomerular endothelial cells synthesize collagens but little gelatinase A and B.

2. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy.

3. High glucose activates PKC-ζ and NADPH oxidase through autocrine TGF-β1 signaling in mesangial cells

4. Type IV Collagen Is Transcriptionally Regulated by Smad1 under Advanced Glycation End Product (AGE) Stimulation

5. Reversibility of Glucose-Induced Changes in Mesangial Cell Extracellular Matrix Depends on the Genetic Background

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole transcriptome mapping reveals the lncRNA regulatory network of TFP5 treatment in diabetic nephropathy;Genes & Genomics;2024-03-27

2. Bioinformatics-based analysis of core genes and pathway enrichment in early diabetic nephropathy;Cellular and Molecular Biology;2023-07-31

3. Ultrastructural comparison of human kidney organoids and human fetal kidneys reveals features of hyperglycemic culture;2023-03-27

4. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis;International Journal of Molecular Sciences;2022-12-28

5. Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells;Clinical and Translational Medicine;2022-12